An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT06464679 · RECRUITING

Trial details

NCT number: NCT06464679
Sponsor: Changhai Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2024-06-27
Primary completion: 2025-12-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.